While doctors already face many challenges in treating patients with cancer, treating pregnant women with the disease, in particular, can be quite difficult as studies suggest that certain therapies can harm developing fetuses. According to the results of a new study expectant women treated with imatinib, a commonly used therapy for chronic myeloid leukemia, may be at moderate risk of developing fetal abnormalities.